retatrutide reaults 🚨 JUST RELEASED TODAY!!!! NEW PHASE 3 DATA Today, July 23, 2026, new Phase 3 retatrutide results were released, adding to what is already one of the most interesting obesity drug The data just dropped —

Weight loss takes longer, but is usually seen after eight to 12 weeks to the tune of ~five percent of total body weight.

Similarly, the SURMOUNT trials for weight management did not report elevated rates of sore throat compared to placebo

Participants continued to have weight loss at week 48 without reaching a plateau, indicating that even greater weight loss might be achievable with extended ecnoglutide treatment, lead researcher Dr

That triple mechanism changes everything about how the compound affects appetite, metabolism, and fat oxidation

By month 3, most users describe eating as purely functional

The odds of a continued downward trend are